This chemical is primarily utilized in the development of pharmaceutical compounds, particularly in the synthesis of drugs targeting central nervous system disorders. It acts as a key intermediate in the production of selective serotonin reuptake inhibitors (SSRIs) and other antidepressants. Its structural properties enable it to interact with specific neurotransmitter systems, making it valuable for designing molecules that modulate brain chemistry. Additionally, it is explored in research for potential applications in treating anxiety and mood disorders due to its ability to influence receptor activity. Its fluorinated aromatic component enhances its binding affinity and metabolic stability, contributing to its effectiveness in drug formulations.